J Dig Cancer Res.  2019 Dec;7(2):45-50. 10.0000/jdcr.2019.7.2.45.

Management of T1 Rectal NEN

Affiliations
  • 1Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Korea. pinetrees@daum.net

Abstract

Incidence of rectal neuroendocrine neoplasms (NEN) has increased tremendously over the decades due to disease awareness and widespread use of screening colonoscopy. Although NEN has been recognized as malignant disease, most rectal NENs are initially found as small mass confined to the submucosa, which can be removed completely through various endoscopic treatments with good prognosis. In this review, we summarize the treatment options focusing on localized T1 rectal NEN by comparing representative international guidelines and discuss current controversies on the management. We also discuss various resection techniques focusing on endoscopic resection.

Keyword

Rectal neuroendocrine tumor; Endoscopic treatment; Management

MeSH Terms

Colonoscopy
Incidence
Mass Screening
Prognosis
Full Text Links
  • JDCR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr